Is amoxicillin/clavulanic acid the best option to treat early-onset ventilator-acquired pneumonia in brain-injured patients

J Glob Antimicrob Resist. 2021 Dec:27:247-249. doi: 10.1016/j.jgar.2021.10.013. Epub 2021 Oct 26.

Authors

A Premachandra¹, A Mazeraud², C Schimpf², R Tortuyaux², C Legouy², M Daniel², X Sauvageon², A Benmostefa³, A Sermet², T Sharshar², M Wolff²

Affiliations

¹ GHU Paris Psychiatrie et Neuroscience, Neurointensive Care and Neuroanesthesia Department, 1 rue Cabanis, 75014, Paris, France. Electronic address: antoine.prema@gmail.com.
² GHU Paris Psychiatrie et Neuroscience, Neurointensive Care and Neuroanesthesia Department, 1 rue Cabanis, 75014, Paris, France.
³ GHU Paris Psychiatrie et Neuroscience, Microbiology Department, 1 rue Cabanis, 75014, Paris, France.

PMID: 34715350
DOI: 10.1016/j.jgar.2021.10.013

No abstract available

Publication types

Letter

MeSH terms

Amoxicillin-Potassium Clavulanate Combination* / therapeutic use
Brain Injuries*
Humans
Pneumonia, Ventilator-Associated* / drug therapy
Ventilators, Mechanical

Substances

Amoxicillin-Potassium Clavulanate Combination